Can weight loss in adulthood reduce the risk of developing colorectal adenomas?
March 2022. While obesity is a known risk factor for colorectal cancer (CRC), the impact of weight change on the development of adenomas, a type of precancerous polyp, is not well understood. A new study published in JNCI Cancer Spectrum found that weight loss among adults, particularly for those who are overweight or obe...
CONTINUE READING
The emotional impact of a colorectal cancer diagnosis
https://youtu.be/-Oi2jBJDUNc February 2022. Join Patient Support Specialist, Chana, as she discusses the emotional impact of a colorectal cancer diagnosis on early age onset patient Lisa Martin. With a three-year-old at home and amidst her active life and thriving career, Lisa was diagnosed with stage 2 colon cancer. Liste...
CONTINUE READING
ASCO GI 2022: Trial evaluating immunotherapy in neoadjuvant setting for the treatment of locally advanced rectal cancer
January 2022 Total neoadjuvant therapy (TNT) is a standard approach for the treatment of locally advanced rectal cancer (stage II/III) that has been shown to produce better pathologic complete response (pCR), as well as improvements to disease-free survival (DFS), overall survival (OS), while reducing the risk of distant ...
CONTINUE READING
ASCO GI 2022: Key considerations about oxaliplatin for the treatment of mCRC
January 2022 Oxaliplatin is an important intravenous chemotherapy drug that is used to treat advanced colorectal cancer (CRC). It is usually given in combination with other chemotherapy drugs, like fluorouracil and leucovorin (e.g. FOLFOX – FOlinic acid + Fluorouracil + OXaliplatin). Oxaliplatin is considered the most neu...
CONTINUE READING
Webinar: Supporting individuals awaiting an ostomy and those living with one
January 2022. Laura Ferguson, a current ileostomy patient, and Karen Bruton, an ostomy nurse, explore topics including the emotional impact of an ostomy, HomeCare resources, tips for ostomy care, and how to best prepare for ostomy surgery. https://youtu.be/gtjUpeaebZM...
CONTINUE READING
